MDS with isolated deletion of the long arm of chromosome 5 [MDS‐del(5q)] is a distinct sub‐entity of MDS characterized by superior outcomes, a favorable response to lenalidomide, and enrichment of SF3B1 mutations [86]. The gene discussed is SF3B1; the disease is myelodysplastic syndrome.